Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

Cytosolic MYSM1 in Hematopoietic Stem Cells and Implications for MYSM1-Deficiency Syndrome Pathology

FY 2021-22

Summary
MYSM1-deficiency syndrome is a rare disorder that presents with severe defects in blood and immune cell development in humans. It is caused by mutations in MYSM1, a DNA binding protein that is known to promote gene expression. Based on previous research it has been established that MYSM1 maintains the function of blood and immune cell development by regulating genes within the nucleus. Recently it has been shown that a pool of MYSM1 protein has been found outside the nucleus (cytosol) in a subset of white blood cells known as macrophages. Functionally, cytosolic MYSM1 is said to be involved in regulating the immune system by decreasing the bodys inflammatory response. The significance of cytosolic MYSM1 has not been explored beyond macrophages and this important knowledge gap will be addressed in my project. This project will focus on determining if a cytosolic pool of MYSM1 protein is produced in blood stem cells (HSCs) when the body is inflamed or infected. If a cytosolic form of MYSM1 protein is found in HSCs then further studies using mutated forms of MYSM1 will be done to further understand how it may contribute to MYSM1-deficiency syndrome. HSCs from mouse bone marrow will be exposed to a range of inflammatory stimuli and imaged to determine the location of MYSM1 within the cell. These studies will be done with harvested HSCs and live mice. We will analyze and compare responses to inflammatory stimuli in HSCs expressing normal and mutated forms of MYSM1 protein. The proposed experiments will provide insight into how cytosolic MYSM1 helps regulate blood and immune cell development in response to inflammation or infection. This work will hopefully be expanded to humans to better understand MYSM1-deficiency syndrome to help future patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
467055
Name
Plackoska Viktoria
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cytosolic MYSM1 in Hematopoietic Stem Cells and Implications for MYSM1-Deficiency Syndrome Pathology
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Hematopoiesis; Hematopoietic Stem Cells; Imaging; Infection; Inflammation; Innate Immunity; Macrophages; Mouse Models; Mysm1 Deficiency Syndrome
Abstract
MYSM1-deficiency syndrome is a rare disorder that presents with severe defects in blood and immune cell development in humans. It is caused by mutations in MYSM1, a DNA binding protein that is known to promote gene expression. Based on previous research it has been established that MYSM1 maintains the function of blood and immune cell development by regulating genes within the nucleus. Recently it has been shown that a pool of MYSM1 protein has been found outside the nucleus (cytosol) in a subset of white blood cells known as macrophages. Functionally, cytosolic MYSM1 is said to be involved in regulating the immune system by decreasing the bodys inflammatory response. The significance of cytosolic MYSM1 has not been explored beyond macrophages and this important knowledge gap will be addressed in my project. This project will focus on determining if a cytosolic pool of MYSM1 protein is produced in blood stem cells (HSCs) when the body is inflamed or infected. If a cytosolic form of MYSM1 protein is found in HSCs then further studies using mutated forms of MYSM1 will be done to further understand how it may contribute to MYSM1-deficiency syndrome. HSCs from mouse bone marrow will be exposed to a range of inflammatory stimuli and imaged to determine the location of MYSM1 within the cell. These studies will be done with harvested HSCs and live mice. We will analyze and compare responses to inflammatory stimuli in HSCs expressing normal and mutated forms of MYSM1 protein. The proposed experiments will provide insight into how cytosolic MYSM1 helps regulate blood and immune cell development in response to inflammation or infection. This work will hopefully be expanded to humans to better understand MYSM1-deficiency syndrome to help future patients.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Plackoska, Viktoria
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~